RECRUITING

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Description

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Conditions

Adolescent BehaviorPediatric CancerOncology
Talk to us

Related Conditions:

Adolescent BehaviorPediatric CancerOncology

Study Overview

On this page

Study Details

Study overview

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Symptom Reporting by Children, Adolescents and Young Adults With Cancer and Their Caregivers During a Clinic Visit: A Feasibility, Usability and Acceptability Study

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Condition
Adolescent Behavior
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94304

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. First diagnosis of cancer
  • 2. Receiving cancer therapy: surgery, myelosuppressive chemotherapy and/or radiation
  • 3. 7-21 years of age
  • 4. Completed at least 1 month of cancer chemotherapy treatment and are within 7-28 days of starting a treatment cycle or during ongoing therapy, followed at least every month in clinic
  • 5. If surgery was part of treatment, the patient must be 3-6 weeks post surgery before participating in study
  • 6. Caregiver must be present and 18 years and older.
  • 7. Ability to understand and the willingness to personally sign the written IRB approved informed consent or assent document as appropriate.
  • 1. Child must be able to read or listen to and understand English and not have cognitive/memory impairments determined by the child's clinician
  • 2. Caregiver must be able to read and understand English.

Ages Eligible for Study

7 Years to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Kimberly Pyke-Grimm, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2025-12